A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of uncertain source.
Several professionals stated the popularity for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, prosecution or prison.
Platform Response and Content Removal
According to the social media company, the platform has removed violative content and prohibited associated hashtags and search suggestions. The organization stated it was committed to keeping the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or administering at residence.
After moments of joining one community, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Product Details and Pricing
Within these groups, messages show black plastic packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for Telegram said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.
